PRE-FUNDED COMMON SHARES PURCHASE WARRANT INMED PHARMACEUTICALS INC.Security Agreement • October 30th, 2023 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 30th, 2023 Company Industry JurisdictionTHIS PRE-FUNDED COMMON SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Shares. The purchase price of one share of Common Shares under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PRE-FUNDED COMMON SHARES PURCHASE WARRANT INMED PHARMACEUTICALS INC.Security Agreement • September 14th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 14th, 2022 Company Industry JurisdictionTHIS PRE-FUNDED COMMON SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to __________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Shares. The purchase price of one share of Common Shares under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PLACEMENT AGENT COMMON SHARE PURCHASE WARRANT ANTELOPE ENTERPRISE HOLDINGS ltd.Security Agreement • August 13th, 2021 • Antelope Enterprise Holdings LTD • Structural clay products
Contract Type FiledAugust 13th, 2021 Company IndustryTHIS PLACEMENT AGENT COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Dawson James Securities, Inc. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the six month anniversary of the Issue Date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 16, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Antelope Enterprise Holdings Ltd., a company formed in the British Virgin Islands (the “Company”), up to 58,824 Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued by the Company as of the date hereof pursuant to Section 3 of the Engagement Agreement, dated as of February 4, 2021, between
COMMON SHARE PURCHASE WARRANT BRIACELL THERAPEUTICS CORP.Security Agreement • June 4th, 2021 • BriaCell Therapeutics Corp. • Pharmaceutical preparations
Contract Type FiledJune 4th, 2021 Company IndustryTHIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on December 7, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BriaCell Therapeutics Corp., a British Columbia corporation (the “Company”), up to ______ common shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one common share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON SHARE PURCHASE WARRANT AETERNA ZENTARIS iNC.Security Agreement • February 21st, 2020 • Aeterna Zentaris Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 21st, 2020 Company IndustryTHIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February 21, 2020 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on August 21, 2025 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Aeterna Zentaris Inc., a Canadian corporation (the “Company”), up to ______ common shares (as subject to adjustment hereunder, the “Warrant Shares”) in the capital of the Company. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).